ev3: Your endovascular company
A pivotal moment for our company has arrived. We have developed best-in-class technologies that enable us to evolve and work toward our vision of endovascular excellence. We now stand on this foundation, united in our intent to help patients embrace the gifts of health and life by providing physicians with an unrivaled offering of endovascular therapy tools.
Tools and technology, however, are just the beginning. Behind our success is a shared commitment to delight customers, motivate employees, and satisfy shareholders. Our patients are at the very heart of this three-fold convergence. This alignment of convictions makes us truly unique within our industry. It is, quite simply, our driving force.
I would like to thank the entire ev3 team for its superb efforts during 2009 and the excellent progress we have made toward fulfilling our vision to be the best at identifying and treating peripheral arterial and neurovascular disease, leading with breakthrough technologies and processes.
Finally, all of us at ev3 appreciate the loyal support of our hospital customers, clinicians, patients, and shareholders. We look forward to reporting on our progress during the months ahead.
Sincerely yours,
Robert J. Palmisano
President and Chief Executive Officer
Print
